MeriCal, Inc.

MeriCal, Inc. is a specialized company focused on developing and manufacturing high-quality health supplements, particularly probiotics and gummies, aimed at enhancing digestive health and overall wellness. MeriCal, Inc. develops and manufactures health supplements, emphasizing probiotics and gummies.

Founded in 1965 in Anaheim, US, the company has undergone strategic changes to expand its product offerings. The current CEOs are Mark Walsh and Ron Fugate. MeriCal has engaged in two significant deals, with the most recent on November 1, 2018. MeriCal specializes in the development and manufacturing of high-quality health supplements, focusing on probiotic formulations and gummies.

Their offerings include clinically-backed probiotic products designed to support digestive health and overall wellness. The company addresses market challenges through innovative research, creating effective supplements for health-conscious consumers, retailers, and health brands seeking robust formulations. Their distribution spans North America, Europe, and select regions of Asia, ensuring accessibility for users seeking reliable dietary supplements. MeriCal generates revenue primarily through B2B partnerships with retailers and health brands, providing tailored manufacturing solutions that include private label services.

Transactions typically involve contract agreements with clients ordering specific supplement quantities, often on a subscription basis. The pricing structure accommodates various client needs, particularly for flagship products like proprietary probiotic formulations and gummies. The company prioritizes on-time, in-full delivery to enhance client satisfaction and foster long-term relationships, with additional revenue streams from collaborations on co-branded products and customized solutions. MeriCal plans to launch new probiotic formulations and gummy products in the upcoming year, targeting health-conscious consumers.

The company aims to expand its presence in Europe and Asia by 2025, leveraging recent funding from their deal on November 1, 2018, to support product development and market expansion initiatives.